Back to 
SCOTIA CAPITAL INC.
SCOTIA CAPITAL INC.
XENE
Showing 0 of 18 quarters
Position history for SCOTIA CAPITAL INC.'s holdings in XENON PHARMACEUTICALS INC
No. Scotia Capital exited its XENE (Xenon Pharmaceuticals) position in Q1 2023. Its Q4 2022 13F listed 26,859 shares worth $1.1M. Scotia Capital already held XENE in its Q4 2018 13F, the earliest on record, and held it in 17 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.